SQZ Biotechnologies (SQZ) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    SQZ Biotechnologies

    NYSE: SQZ · Real-Time Price · USD
    0.43
    0.16 (59.26%)
    At close: Jul 03, 2023, 7:00 PM

    SQZ Biotechnologies Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 10.19M 24.71M 39.87M 63.71M 84.24M 105.56M 122.91M 143.51M 164.25M 185.07M 204.93M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 2.31M 2.31M 2.31M 2.31M 2.61M 2.62M 2.63M 2.63M 2.31M 2.31M 2.31M
    Receivables
    		 n/a n/a n/a 384K n/a n/a n/a 3M n/a 52K 28K
    Inventory
    		 n/a n/a n/a -384K n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 1.89M 2.98M 4.58M 4.5M 3.1M 4.49M 5M 4.12M 1.91M 4.14M 6.16M
    Total Current Assets
    		 12.09M 27.68M 44.45M 68.2M 87.34M 110.05M 127.92M 150.63M 166.17M 189.26M 211.11M
    Property-Plant & Equipment
    		 15.4M 24.16M 26.4M 29.39M 64.91M 67.64M 70.25M 72.89M 75.6M 46.99M 49.45M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 17.7M 26.46M 28.71M 31.7M 67.52M 70.26M 72.88M 75.52M 77.91M 49.29M 51.76M
    Total Assets
    		 29.79M 54.15M 73.16M 99.9M 154.85M 180.31M 200.8M 226.15M 244.07M 238.55M 262.87M
    Account Payables
    		 1.91M 1.56M 2.48M 2.51M 3.31M 1.66M 1.2M 3.97M 2.39M 2.1M 3.95M
    Deferred Revenue
    		 n/a 500K 678K 715K 3.5M 6.63M 9.64M 12.51M 21.86M 26.61M 25.52M
    Short-Term Debt
    		 2.4M 2.66M 4.19M 6.56M 10.63M 10.45M 10.13M 9.94M 9.2M 9.88M 8.37M
    Other Current Liabilities
    		 4.52M 5.19M 5.34M 12.05M 7.82M 9.71M 8.53M 6.81M 5.66M 5.25M 4.54M
    Total Current Liabilities
    		 8.83M 9.91M 12.69M 21.84M 25.26M 28.44M 29.5M 33.22M 39.11M 43.84M 42.38M
    Long-Term Debt
    		 19.07M 19.7M 20.31M 20.91M 51.82M 54.48M 57.19M 59.76M 62.36M 32.61M 36.4M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a n/a n/a n/a 205K 205K 205K
    Total Long-Term Liabilities
    		 19.07M 19.7M 20.31M 20.91M 61.02M 63.68M 66.38M 68.95M 71.76M 42.02M 51.21M
    Total Liabilities
    		 27.91M 29.61M 33M 42.75M 86.28M 92.12M 95.88M 102.18M 110.87M 85.85M 93.59M
    Total Debt
    		 21.47M 22.36M 24.5M 27.47M 62.45M 64.93M 67.32M 69.69M 71.56M 42.49M 44.77M
    Common Stock
    		 29K 29K 29K 29K 29K 29K 28K 28K 28K 28K 28K
    Retained Earnings
    		 -333.07M -309.43M -292.66M -274.97M -261.43M -238.78M -216.55M -195.51M -183.69M -161.24M -142.17M
    Comprehensive Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.09M -3.86M
    Shareholders Equity
    		 1.88M 24.54M 40.16M 57.15M 68.57M 88.19M 104.91M 123.98M 133.21M 152.7M 169.28M
    Total Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist